Erica Kratz

General Counsel at AURA BIOSCIENCES, INC.

Net worth: 619 434 $ as of 30/10/2026

Health Technology

Consumer Services

Profile

Erica Kratz is Chief Regulatory & Quality Officer at Aura Biosciences, Inc. since 2026.
Formerly, Dr. Kratz was Vice President-Regulatory at Denali Therapeutics, Inc. from 2022 to 2026.
Education includes undergraduate studies at the University of Arizona and a doctorate from the University of California.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
AURA BIOSCIENCES INC 0.1%	31/08/2026	100,885 ( 0.1% )	619 434 $	30/10/2026

Erica Kratz active positions

Companies	Position	Start
AURA BIOSCIENCES, INC.	General Counsel	10/08/2026

All active positions of Erica Kratz

Former positions of Erica Kratz

Companies	Position	End
DENALI THERAPEUTICS INC.	General Counsel	30/04/2026

See the detail of Erica Kratz's experience

Education of Erica Kratz

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Erica Kratz's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Aura Biosciences, Inc. Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications	Health Technology
University of Arizona University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of California University of California Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Denali Therapeutics, Inc. Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases	Health Technology